Skip to content
Third-Party Risk Management for Life Sciences
Ethixbase360 smart automation with expert-led due diligence and responsive support gives our clients a clear, connected view of global third-party risk to withstand regulatory scrutiny and address complex global value chains with speed, flexibility and responsiveness.
Driving transparency, compliance, and resilience across your global third-party ecosystem.
The Ethixbase360 third-party risk management platform brings together intelligent automation, expert-led due diligence, and responsive support — giving Life Sciences organizations a unified global view of third-party risk to meet evolving regulatory demands and manage complex value chains with speed and agility.
Pressures of Life Sciences Today
Escalating Regulatory Demands
With global compliance standards evolving across anti-bribery, sanctions, and ethical sourcing, risk teams must adapt quickly to avoid costly enforcement actions, product disruptions, and reputational harm.
Complex Global Value Chains
Life Sciences organizations rely on vast, interconnected supplier networks. Without centralized oversight, siloed local approaches create blind spots and increase exposure to hidden risks.
Reputational Vulnerability
Even a single third-party misstep can result in public scrutiny and reputational harm. In Life Sciences, trust is everything and it can be lost in an instant.
Integrated risk intelligence
Gain a connected, real-time view of third-party risk, enabling you to act quickly, meet regulatory demands.
- Rapid onboarding with built-in pre-screening workflows
- Instant entity verification and alerts
- Risk-based screening, escalation, and investigation, all in one platform.
Compliance at the heart of operations
Demonstrate compliance across global regulatory frameworks while creating a transparent, defensible compliance culture.
- Configurable Enhanced Due Diligence tailored to your needs
- Seamless vendor assessments (e.g., anti-bribery, modern slavery)
- Policy distribution and confirmation tracking for third-party accountability.
A platform built around you
Drive adoption across the enterprise, eliminate silos, and scale oversight efficiently across global operations.
- SSO, API connectivity, and reporting integrations
- Automated approvals, questionnaires, and case management
- Standardized reporting and business intelligence for faster decisions.
Proof from the Industry.
See how leading life sciences companies solved compliance challenges with our platform.
Ready to Transform Your
Third-Party Risk Management?
Discover how Ethixbase360 can help your organization build a transparent, compliant, and resilient third-party ecosystem.
“Ethixbase360 has been really helpful and responsive. The platform itself is very user-friendly and everything now is much more organized for us and there’s a lot more automation in the process now. They have been really helpful with not just the product, but also suggestions. They’ve sometimes steered us towards more cost-effective things that would provide a similar level of protection. I’ve never been frustrated with waiting for a response.”
Group Compliance Manager, Global Medical Devices Suppliers
“Everything is valuable in Ethixbase360’s platform, from the moment they trigger the automatic email directly to the third parties, the third parties respond directly via the platform, the Enhanced Due Diligence (EDD) reports are good, the Instant Due Diligence Plus (IDD+) is a very good complement for changes in management. The whole process is very useful.”
Head Group of Compliance
Fortune 500 Pharmaceutical Company
Resources
Our Latest News, Case Studies, Webinars & More
Trade, Tariffs, and Terrorism Webinar Takeaways
Global trade has always been complex but in 2025, the pace and unpredictability of change have reached new heights. From shifting tariff regimes and export controls to new terrorism designations.[...]
The Business Case for Modern Slavery and Human Rights Compliance in Australia
Australia’s Modern Slavery Act 2018 (Cth) requires thousands of companies to report annually on how they identify and manage risks of modern slavery in their operations and supply chains.[...]
What the new BIS 50% Rule Means for Third-Party Screening & Ownership Due Diligence
On September 29, 2025, the Bureau of Industry and Security of the US Department of Commerce (“BIS”) issued a new interim final rule [...]
The Importance of TPRM in Facilitating Ethical Transactions with HCPs
In the Life Sciences industry, maintaining ethical and transparent relationships with healthcare professionals (HCPs) is fundamental to trust, patient safety, and business integrity. [...]
Agility, Innovation & Strong (Ethical) Foundations
Earlier this month, Ethixbase360 was delighted to sponsor the third annual Risk & Compliance Pharma & Life Sciences Conference, held in London. [...]
